Drug Profile
Donepezil/glycopyrrolate - Sio Gene Therapies
Alternative Names: RVT 103Latest Information Update: 28 Sep 2023
Price :
$50
*
At a glance
- Originator Axovant Sciences
- Developer Sio Gene Therapies
- Class Acetates; Antidementias; Benzene derivatives; Benzyl compounds; Cyclopentanes; Ethers; Indans; Ketones; Nootropics; Piperidines; Pyrrolidines; Pyrrolidinones; Quaternary ammonium compounds; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease; Lewy body disease
Most Recent Events
- 19 Sep 2023 Chemical structure information added
- 05 Apr 2023 Discontinued - Phase-I for Alzheimer's disease (In the elderly, In volunteers) in USA (unspecified route) (Sio Gene Therapies website, April 2023)
- 05 Apr 2023 Discontinued - Phase-I for Lewy body disease (In the elderly, In volunteers) in USA (unspecified route) (Sio Gene Therapies website, April 2023)